Pensionsversicherungsanstalt
7
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Changes in Faecal Calprotectin Levels and Participation-related Scores Following Three Weeks of Inpatient Rehabilitation
Role: lead
Development of a Research Agenda for Rehabilitation Research
Role: lead
Changes in Workability and Employment Following the Work-related Medical Rehabilitation PV RehaJET
Role: lead
Effectiveness of a Resilience-Based Rehabilitation Program for Patients with Coronary Heart Disease
Role: lead
Evaluation of Immediate and Medium-term Health- and Work-related Effects Following Inpatient Psychocardiological Rehabilitation
Role: lead
Changes in Selected Function- and Participation-related Characteristics in Post-COVID Patients Following Pneumological Phase II Rehabilitation
Role: lead
Evaluation of Telerehabilitation Following Inpatient or Outpatient Rehabilitation Phase II
Role: lead
All 7 trials loaded